Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells

International Immunology

Volumn 22, Issue 4, 2010, Pages 271-280

  Tsukamoto, Hiroki ^a   Fukudome, Kenji ^a   Takao, Shoko ^a   Tsuneyoshi, Naoko ^a   Kimoto, Masao ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Antibody; Cell surface molecule; Innate immunity; Signal transduction

Indexed keywords

CD14 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN MD 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD14; CARRIER PROTEINS; CELL LINE; CELL MEMBRANE; DOWN-REGULATION; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN MULTIMERIZATION; RATS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 77954036715     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq005     Document Type: Article

References (46)

1. Janeway, C. A., Jr. and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
2. Akira, S. and Takeda, K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499.
3. Nagai, Y., Akashi, S., Nagafuku, M. et al. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:667.
4. Akashi, S., Shimazu, R., Ogata, H. et al. 2000. Cutting edge: cell surface expression and lipopolysaccharide signaling via the tolllike receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164:3471.
5. Kim, H. M., Park, B. S., Kim, J. I. et al. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906.
6. Galanos, C., Luderitz, O., Rietschel, E. T. et al. 1985. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148:1.
7. Akashi, S., Nagai, Y., Ogata, H. et al. 2001. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13:1595.
8. Dixon, D. R. and Darveau, R. P. 2005. Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J. Dent. Res. 84:584.
9. Tsuneyoshi, N., Kohara, J., Bahrun, U. et al. 2006. Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction. Cell. Immunol. 244:57.
10. Tsuneyoshi, N., Fukudome, K., Kohara, J. et al. 2005. The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1. J. Immunol. 174:340.
11. Ulevitch, R. J. and Tobias, P. S. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437.
12. Lee, J. D., Kato, K., Tobias, P. S., Kirkland, T. N. and Ulevitch, R. J. 1992. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 175:1697.
13. Heumann, D., Gallay, P., Barras, C. et al. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148:3505.
14. Bazil, V. and Strominger, J. L. 1991. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147:1567.
15. Durieux, J. J., Vita, N., Popescu, O. et al. 1994. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur. J. Immunol. 24:2006.
16. Han, J., Mathison, J. C., Ulevitch, R. J. and Tobias, P. S. 1994. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J. Biol. Chem. 269:8172.
17. Juan, T. S., Kelley, M. J., Johnson, D. A. et al. 1995. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270:1382.
18. Hailman, E., Lichenstein, H. S., Wurfel, M. M. et al. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269.
19. Pugin, J., Schurer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J. and Tobias, P. S. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl Acad. Sci. USA 90:2744.
20. Theofan, G., Horwitz, A. H., Williams, R. E. et al. 1994. An aminoterminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J. Immunol. 152:3623.
21. Gay, N. J., Gangloff, M. and Weber, A. N. 2006. Toll-like receptors as molecular switches. Nat. Rev. Immunol. 6:693.
22. Latz, E., Verma, A., Visintin, A. et al. 2007. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8:772.
23. Visintin, A., Iliev, D. B., Monks, B. G., Halmen, K. A. and Golenbock, D. T. 2006. MD-2. Immunobiology 211:437.
24. Gangloff, M. and Gay, N. J. 2004. MD-2: the Toll 'gatekeeper' in endotoxin signalling. Trends Biochem. Sci. 29:294.
25. Zhang, H., Tay, P. N., Cao, W., Li, W. and Lu, J. 2002. Integrinnucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Lett. 532:171.
26. Visintin, A., Latz, E., Monks, B. G., Espevik, T. and Golenbock, D. T. 2003. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J. Biol. Chem. 278:48313.
27. Schmitz, G. and Orso, E. 2002. CD14 signalling in lipid rafts: new ligands and co-receptors. Curr. Opin. Lipidol. 13:513.
28. Triantafilou, M. and Triantafilou, K. 2005. The dynamics of LPS recognition: complex orchestration of multiple receptors. J. Endotoxin Res. 11:5.
29. Shawkat, S., Karima, R., Tojo, T. et al. 2008. Visualization of the molecular dynamics of lipopolysaccharide on the plasma membrane of murine macrophages by total internal reflection fluorescence microscopy. J. Biol. Chem. 283:22962.
30. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H. and Lee, J. O. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191.
31. Lee, H. K., Dunzendorfer, S. and Tobias, P. S. 2004. Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by b-lactamase enzyme fragment complementation. J. Biol. Chem. 279:10564.
32. Kobayashi, M., Saitoh, S., Tanimura, N. et al. 2006. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 176:6211.
33. Saitoh, S., Akashi, S., Yamada, T. et al. 2004. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int. Immunol. 16:961.
34. Akashi, S., Saitoh, S., Wakabayashi, Y. et al. 2003. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198:1035.
35. Bahrun, U., Kimoto, M., Tsukamoto, H., Tsuneyoshi, N., Kohara, J. and Fukudome, K. 2007. Preparation and characterization of agonistic monoclonal antibodies against Toll-like receptor 4-MD-2 complex. Hybridoma (Larchmt) 26:393.
36. Tsukamoto, H., Fukudome, K., Kohara, J., Nakatake, H. and Kimoto, M. 2007. Preparation of recombinant murine tumor necrosis factor-α in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography. Protein Expr. Purif. 56:138.
37. Yonemura, H., Imamura, T., Soejima, K. et al. 2004. Preparation of recombinant α-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin. J. Biochem. 135:577.
38. da Silva Correia, J. and Ulevitch, R. J. 2002. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277:1845.
39. Fujimoto, T., Yamazaki, S., Eto-Kimura, A., Takeshige, K. and Muta, T. 2004. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J. Biol. Chem. 279:47431.
40. Ohnishi, T., Muroi, M. and Tanamoto, K. 2003. MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin. Diagn. Lab. Immunol. 10:405.
41. Grunwald, U., Fan, X., Jack, R. S. et al. 1996. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J. Immunol. 157:4119.
42. Schiff, D. E., Kline, L., Soldau, K. et al. 1997. Phagocytosis of gram-negative bacteria by a unique CD14-dependent mechanism. J. Leukoc. Biol. 62:786.
43. Dunzendorfer, S., Lee, H. K., Soldau, K. and Tobias, P. S. 2004. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J. Immunol. 173:1166.
44. Blander, J. M. and Medzhitov, R. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014.
45. Doyle, S. E., O'Connell, R. M., Miranda, G. A. et al. 2004. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199:81.
46. Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S. and Medzhitov, R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol. 9:361.